China Pharma Holdings Inc
CPHI0.694USD
+0.034+5.37%
收盘 02/06, 16:00（美东）报价延迟15分钟
3.48M总市值
亏损市盈率 TTM
关于 China Pharma Holdings Inc 公司
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
China Pharma Holdings Inc简介
公司代码CPHI
公司名称China Pharma Holdings Inc
上市日期Feb 15, 2000
CEOLi (Zhilin)
员工数量224
证券类型Ordinary Share
年结日Feb 15
公司地址2nd Floor, No. 17, Jinpan Road
城市HAIKOU
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家China
邮编570216
电话8689866811730
网址http://www.chinapharmaholdings.com
公司代码CPHI
上市日期Feb 15, 2000
CEOLi (Zhilin)
China Pharma Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
+1.00%
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
+1.00%
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
+1.00%
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
+1.00%
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
业务USD
名称
营收
占比
Domestic Pharmaceuticals
756.22K
0.00%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Domestic Pharmaceuticals
756.22K
0.00%
股东统计
更新时间: 1月2日 周五
更新时间: 1月2日 周五
持股股东
股东类型
持股股东
持股股东
占比
Yang (Yan)
8.96%
Zhan (Wenlong)
8.16%
Jianying (Cai)
7.96%
Lai (Kui)
7.96%
Lihua (Li)
7.96%
其他
58.98%
持股股东
持股股东
占比
Yang (Yan)
8.96%
Zhan (Wenlong)
8.16%
Jianying (Cai)
7.96%
Lai (Kui)
7.96%
Lihua (Li)
7.96%
其他
58.98%
股东类型
持股股东
占比
Individual Investor
53.39%
Hedge Fund
0.82%
Investment Advisor
0.01%
其他
45.78%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
15
76.44K
2.51%
--
2025Q3
15
76.44K
3.87%
-42.24K
2025Q2
15
118.68K
1.40%
+84.90K
2025Q1
14
33.79K
0.88%
+5.19K
2024Q4
14
17.38K
1.34%
+13.31K
2024Q3
13
4.07K
1.47%
-1.93K
2024Q2
13
6.00K
1.31%
-5.59K
2024Q1
11
11.59K
0.89%
-1.57K
2023Q4
12
12.24K
0.98%
+6.13K
2023Q3
12
6.11K
1.50%
+3.00K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Yang (Yan)
450.00K
8.96%
+450.00K
--
Nov 03, 2025
Zhan (Wenlong)
410.00K
8.16%
+410.00K
--
Nov 03, 2025
Jianying (Cai)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Lai (Kui)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Lihua (Li)
400.00K
7.96%
+300.00K
+300.00%
Nov 03, 2025
Li (Zhilin)
302.76K
6.03%
+1.00
+0.00%
Nov 03, 2025
Liu (Tao Chengdu)
300.00K
5.97%
--
--
Nov 03, 2025
Citadel Advisors LLC
30.43K
0.61%
+7.36K
+31.89%
Sep 30, 2025
Tsui (Heung Mei)
18.63K
0.37%
+1.00
+0.01%
Nov 03, 2025
Renaissance Technologies LLC
10.62K
0.21%
+10.62K
--
Sep 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
Apr 04, 2025
Merger
10→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
公告日期
除权除息日
类型
比率
Apr 04, 2025
Merger
10→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
